FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:1523-1524 December 1, 1994 Number 22 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

In an era in which the importance of a scientific advance often appears to be measured by the amount of media coverage it generates, the level of reporting of the recent identification of BRCA1, a susceptibility gene for breast cancer on chromosome 17 and the first such gene to be isolated, suggests that this discovery is the most exciting breakthrough in modern times. Earlier news coverage of the "race" to find BRCA1 was noteworthy for the amount of media attention focused on something that had yet to be accomplished. This general interest in BRCA1 is illustrated by the fact that . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Campbell, H., Mackay, J., Porteous, M. (1995). The future of breast and ovarian cancer clinics. BMJ 311: 1584-1585 [Full Text]